Growth Metrics

Gilead Sciences (GILD) Depreciation & Amortization (CF) (2016 - 2025)

Gilead Sciences' Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $90.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 5.26% year-over-year to $90.0 million; the TTM value through Dec 2025 reached $370.0 million, down 2.89%, while the annual FY2025 figure was $370.0 million, 2.89% down from the prior year.
  • Depreciation & Amortization (CF) reached $90.0 million in Q4 2025 per GILD's latest filing, roughly flat from $90.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $98.0 million in Q2 2024 to a low of $78.0 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $87.8 million, with a median of $90.0 million recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization (CF): fell 7.78% in 2022, then grew 18.07% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $90.0 million in 2021, then decreased by 7.78% to $83.0 million in 2022, then grew by 9.64% to $91.0 million in 2023, then rose by 4.4% to $95.0 million in 2024, then dropped by 5.26% to $90.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Depreciation & Amortization (CF) are $90.0 million (Q4 2025), $90.0 million (Q3 2025), and $93.0 million (Q2 2025).